Abstract
The factor-V-Leiden mutation is seen in high frequencies in white people, despite its contribution to second-trimester abortion, preterm birth, and deep-vein thrombosis. The reason for its high frequency is not known. We investigated 102 mother-child pairs who had had successful in-vitro fertilisation by intracytoplasmic sperm injection as a model for human implantation. In 90% (9 of 10) of mother-child pairs who carried factor-V-Leiden mutation, the first embryo transfer was successful, compared with 49% (45 of 92) in factor-V-Leiden negative pairs (p=0.018, Fisher's exact test). Furthermore, the median number of unsuccessful transfers was lower in pairs who were positive for the mutation (0, range 0-2) than those who were negative (1, 0-8) (p=0.02, Mann Whitney U test) suggesting that improved implantation rate is an important genetic advantage of the factor-V-Leiden mutation.
| Original language | English |
|---|---|
| Journal | Lancet |
| Volume | 358 |
| Issue number | 9289 |
| Pages (from-to) | 1238-1239 |
| Number of pages | 2 |
| ISSN | 0140-6736 |
| DOIs | |
| Publication status | Published - 13.10.2001 |
Funding
This work was supported by grant Go 955/1–1 from the Deutsche Forschungsgemeinschaft and by Grant J 10 from the University of Lübeck.
Research Areas and Centers
- Academic Focus: Center for Brain, Behavior and Metabolism (CBBM)